Aspirin and gastrointestinal cancer

Advances in Experimental Medicine and Biology

Volumn 400, Issue A, 1997, Pages 395-402

  Thun, M J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ADENOMATOUS POLYP; ANIMAL CELL; ANIMAL EXPERIMENT; CANCER RISK; COLORECTAL CANCER; CONFERENCE PAPER; DATA ANALYSIS; DIGESTIVE SYSTEM CANCER; EPIDEMIOLOGICAL DATA; HYPOTHESIS; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RODENT; STOMACH CANCER; SYMPTOMATOLOGY;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; COLONIC NEOPLASMS; COLONIC POLYPS; COLORECTAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS;

ANIMALIA; RODENTIA;

EID: 0031430056     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5325-0_53     Document Type: Article

References (36)

1. Marnett, L.J. Aspirin and the role of prostaglandins in cancer. Cancer Res 52:5575-5589, 1992.
2. Pollard, M. and Luckert, P.H. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 64:1323-7, 1980.
3. Kudo, T., Narisawa, T. and Abo, S. Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 71:260-64, 1980.
4. Pollard, M. and Luckert, P.H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 214:558-9, 1981.
5. Pollard, M. and Luckert, PH. Treatment of chemically-induced intestinal cancers with indomethacin. Proc Soc Exp Biol Med 167:161-4, 1981.
6. Narisawa, T., Sato, M., Tani, M., Kudo, T., Takahashi, T. and Goto, A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41:1954-7, 1981.
7. Pollard, M., Luckert, P.H. and Schmidt, M.A. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett 21:57-61, 1983.
8. Pollard, M. and Luckert, P.H. Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. J Natl Cancer Inst 70:1103-5, 1983.
9. Narisawa, T., Satoh, M., Sano, M. and Takahashi, T. Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. Carcinogenesis 4:1225-7, 1983.
10. Pollard, M. and Luckert, P.H. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett 25:117-121, 1984.
11. 2) against indomethacin. J Cancer Res Clin Oncol 108:239-42, 1984.
12. Metzger, U., Meier, J., Uhlschmid, G. and Weihe, H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum 27:366-9, 1984.
13. Pollard, M. Antitumor effect of indomethacin in rats with autochthonous intestinal tumors. In Frontiers in Gastrointestinal cancer (Levin B, Riddell RH, eds.). New York: Elsevier, pp. 91-103, 1984.
14. Nigro, D.N., Bull, A.W. and Boyd, M.E. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. J Natl Cancer Inst 77:1309-1313, 1986.
15. Reddy, B.S., Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res 47:5340-6, 1987.
16. Moorghen, M., Ince, P., Finney, K., Sunter, J.P., Appleton, D.R. and Watson, A.J. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. Journal of Path 156:341-347, 1988.
17. Pollard, M. and Luckert, P.H. Prevention and treatment of primary intestinal tumors in rats by piroxicam. Cancer Res 49:6471-6473, 1989.
18. Rubio, C.A., Wallin, B., Ware, J., Sveander, M. and Duvander, A. Effect of indomethacin in autotransplanted colonic tumors. Dis Colon Rectum 32:488-491, 1989.
19. Reddy, B.S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. and Kelloff, G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L,-difluromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50:2562-8, 1990.
20. Rao, C.V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. and Reddy, B.S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, -difluoromethylornithine, 16-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51:4528-4534, 1991.
21. Skinner, S.A., Penney, A.G. and O'Brian, P.E. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg 126:1094-6, 1991.
22. Craven, P.A. and Derubertis, F.R. Effects of aspirin on 1,-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 13:541-6, 1992.
23. Labayle, D., Fischer, D. and Vielh, P. et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-9, 1991.
24. Giardiello, F.M., Hamilton, S.R. and Krush, A.J. et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Eng J Med 328:1313-6, 1993.
25. Kune, G., Kune, S. and Watson, L. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melborne Colorectal Cancer Study. Cancer Res 48:4399-404, 1988.
26. Paganini-Hill, A., Chao, A, Ross, R.K. and Henderson, B.E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 229:1247-50, 1989.
27. Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Stolley, P.D. and Shapiro, S. A Hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355-8, 1991.
28. Thun, M., Namboodiri, M. and Heath, C. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596, 1991.
29. Thun, M., Namboodiri, M., Calle, E.E., Flanders, W.D. and Heath, C.W. Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327, 1993.
30. Gridley, G., McLaughlin, J.K., Ekbom A., et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Instit 85;307-311, 1993.
31. Isomaki, H.A., Hakulinen, T. and Joutsenlahti, U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chron Dis 31:691-696, 1978.
32. Heath, C.W. Rheumatoid arthritis, aspirin, and gastrointestinal cancer. J Natl Cancer Instil 85:258-259 (editorial), 1993.
33. Suh, O., Mettlin, C. and Petrelli, N.J. Aspirin use, cancer, and polyps of the large bowel. Cancer 72;1171-7, 1993.
34. Greenberg, E.R., Baron, J.A., Freeman, D.H., Mandel, J.S. and Haile, R. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Instit 85:912-916, 1993.
35. Logan R.F.A., Little J., Hawtin P.G. and Hardcastle J.D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas:case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 307:285-289.
36. Gann, P.H., Manson, J.E., Glynn, J., Buring, J. and Hennekins, C.H. Low-dose aspirin and incidence of colorectal tumors a randomized trial. J Natl Cancer Instit 85:1220-1224, 1993.